Medtronic Insider Trades
NYSE: MDTHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 9 · $5.87M
- Shares bought / sold
- 0 / 61.30K
- Net activity
- Net selling $5.9 million
Medtronic insider activity
Over the last 12 months, Medtronic insiders reported 64 transactions on SEC Form 4: 0 open-market purchases and 9 sales. Insiders bought $0 and sold $5.9 million worth of stock, for net insider selling of $5.9 million. The largest seller was KIIL HARRY SKIP, with $5.6 million in reported sales.
The most recent filing shows KIIL HARRY SKIP (EVP & President Cardiovascular) selling 1,483 shares at $93.65 on Sep 16, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put MDT's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
MDT insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 16, 2026 | KIIL HARRY SKIPEVP & President Cardiovascular | Sale | 1,483 | $138.88K | Form 4 |
| Sep 15, 2026 | Blomquist Denise L.Chief Accounting Officer | Gift | 600 | — | Form 4 |
| Aug 20, 2026 | Marinaro MichaelEVP, Pres MedSurg and Americas | Tax withholding | 1,084 | $100.05K | Form 4 |
| Aug 3, 2026 | Martha GeoffreyChairman and CEO | Award | 41,533 | — | Form 4 |
| Aug 3, 2026 | Marinaro MichaelEVP, Pres MedSurg and Americas | Award | 46,147 | — | Form 4 |
| Aug 3, 2026 | Marinaro MichaelEVP, Pres MedSurg and Americas | Award | 10,960 | — | Form 4 |
| Aug 3, 2026 | KIIL HARRY SKIPEVP & President Cardiovascular | Award | 9,230 | — | Form 4 |
| Aug 3, 2026 | Pieton ThierryEVP & Chief Financial Officer | Award | 11,537 | — | Form 4 |
| Aug 3, 2026 | Quinn MichelleEVP, GC and Secretary | Award | 6,346 | — | Form 4 |
| Aug 3, 2026 | Walter Matthew R.SVP, Chief HR Officer | Award | 5,769 | — | Form 4 |
| Aug 3, 2026 | Thompson KweliEVP & President, Neuroscience | Award | 6,923 | — | Form 4 |
| Aug 3, 2026 | Blomquist Denise L.Chief Accounting Officer | Award | 2,337 | — | Form 4 |
| Jul 31, 2026 | Martha GeoffreyChairman and CEO | Tax withholding | 15,810 | $1.35M | Form 4 |
| Jul 31, 2026 | Marinaro MichaelEVP, Pres MedSurg and Americas | Tax withholding | 3,356 | $286.57K | Form 4 |
| Jul 31, 2026 | KIIL HARRY SKIPEVP & President Cardiovascular | Tax withholding | 3,074 | $262.49K | Form 4 |
| Jul 31, 2026 | Walter Matthew R.SVP, Chief HR Officer | Tax withholding | 1,675 | $143.03K | Form 4 |
| Jul 31, 2026 | Thompson KweliEVP & President, Neuroscience | Tax withholding | 1,739 | $148.49K | Form 4 |
| Jul 31, 2026 | Blomquist Denise L.Chief Accounting Officer | Tax withholding | 212 | $18.10K | Form 4 |
| Jul 28, 2026 | Quinn MichelleEVP, GC and Secretary | Tax withholding | 2,069 | $179.75K | Form 4 |
| Jul 8, 2026 | Walter Matthew R.SVP, Chief HR Officer | Sale | 3,102 | $257.93K | Form 4 |
| Jun 8, 2026 | KIIL HARRY SKIPEVP & President Cardiovascular | Sale | 228 | $18.34K | Form 4 |
| Jun 8, 2026 | KIIL HARRY SKIPEVP & President Cardiovascular | Sale | 3,961 | $318.62K | Form 4 |
| Jun 5, 2026 | Blomquist Denise L.Chief Accounting Officer | Tax withholding | 237 | $19.75K | Form 4 |
| Jun 4, 2026 | Walter Matthew R.SVP, Chief HR Officer | Tax withholding | 2,840 | $236.63K | Form 4 |
| Jun 4, 2026 | Marinaro MichaelEVP, Pres MedSurg and Americas | Tax withholding | 7,471 | $622.48K | Form 4 |
| Jun 4, 2026 | Martha GeoffreyChairman and CEO | Tax withholding | 41,936 | $3.49M | Form 4 |
| Jun 4, 2026 | KIIL HARRY SKIPEVP & President Cardiovascular | Tax withholding | 6,817 | $567.99K | Form 4 |
| May 26, 2026 | Blomquist Denise L.Chief Accounting Officer | Option exercise | 1,712 | — | Form 4 |
| May 26, 2026 | KIIL HARRY SKIPEVP & President Cardiovascular | Option exercise | 15,195 | — | Form 4 |
| May 26, 2026 | Marinaro MichaelEVP, Pres MedSurg and Americas | Option exercise | 18,994 | — | Form 4 |
| May 26, 2026 | Martha GeoffreyChairman and CEO | Option exercise | 94,963 | — | Form 4 |
| May 26, 2026 | Walter Matthew R.SVP, Chief HR Officer | Option exercise | 9,149 | — | Form 4 |
| May 26, 2026 | Wall Brett A.EVP & Pres Neuroscience | Option exercise | 26,907 | — | Form 4 |
| May 1, 2026 | Walter Matthew R.SVP, Chief HR Officer | Tax withholding | 35 | $2.80K | Form 4 |
| Apr 28, 2026 | ARNOLD CRAIGDirector | Tax withholding | 207 | $16.95K | Form 4 |
| Apr 28, 2026 | DONNELLY SCOTT CDirector | Tax withholding | 207 | $16.95K | Form 4 |
| Apr 28, 2026 | Fonseca LidiaDirector | Tax withholding | 207 | $16.95K | Form 4 |
| Apr 28, 2026 | HOGAN RANDALL JDirector | Tax withholding | 207 | $16.95K | Form 4 |
| Apr 28, 2026 | Lewis Gregory PDirector | Tax withholding | 207 | $16.95K | Form 4 |
| Apr 28, 2026 | Lofton Kevin EDirector | Tax withholding | 207 | $16.95K | Form 4 |
| Apr 28, 2026 | Powell Kendall JDirector | Tax withholding | 207 | $16.95K | Form 4 |
| Apr 28, 2026 | NABEL ELIZABETH GDirector | Tax withholding | 207 | $16.95K | Form 4 |
| Apr 28, 2026 | Blomquist Denise L.Chief Accounting Officer | Tax withholding | 318 | $26.04K | Form 4 |
| Apr 27, 2026 | ARNOLD CRAIGDirector | Award | 2,111 | — | Form 4 |
| Apr 27, 2026 | DONNELLY SCOTT CDirector | Award | 2,111 | — | Form 4 |
| Apr 27, 2026 | Fonseca LidiaDirector | Award | 2,111 | — | Form 4 |
| Apr 27, 2026 | Groetelaars John PDirector | Award | 1,444 | — | Form 4 |
| Apr 27, 2026 | HOGAN RANDALL JDirector | Award | 2,111 | — | Form 4 |
| Apr 27, 2026 | Jellison William RDirector | Award | 1,444 | — | Form 4 |
| Apr 27, 2026 | Lewis Gregory PDirector | Award | 2,111 | — | Form 4 |
| Apr 27, 2026 | Lofton Kevin EDirector | Award | 2,111 | — | Form 4 |
| Apr 27, 2026 | Lee Joon SupDirector | Award | 1,803 | — | Form 4 |
| Apr 27, 2026 | Powell Kendall JDirector | Award | 2,111 | — | Form 4 |
| Apr 27, 2026 | NABEL ELIZABETH GDirector | Award | 2,111 | — | Form 4 |
| Apr 27, 2026 | Blomquist Denise L.Chief Accounting Officer | Award | 1,508 | — | Form 4 |
| Mar 3, 2026 | Pieton ThierryEVP & Chief Financial Officer | Tax withholding | 2,976 | $287.81K | Form 4 |
| Feb 19, 2026 | KIIL HARRY SKIPEVP & President Cardiovascular | Sale | 385 | $37.66K | Form 4 |
| Feb 19, 2026 | KIIL HARRY SKIPEVP & President Cardiovascular | Sale | 668 | $65.35K | Form 4 |
| Feb 19, 2026 | KIIL HARRY SKIPEVP & President Cardiovascular | Sale | 19,255 | $1.88M | Form 4 |
| Feb 19, 2026 | KIIL HARRY SKIPEVP & President Cardiovascular | Sale | 30,568 | $2.99M | Form 4 |
| Feb 19, 2026 | KIIL HARRY SKIPEVP & President Cardiovascular | Sale | 1,648 | $161.27K | Form 4 |
| Feb 19, 2026 | KIIL HARRY SKIPEVP & President Cardiovascular | Option exercise | 385 | $30.80K | Form 4 |
| Feb 19, 2026 | KIIL HARRY SKIPEVP & President Cardiovascular | Option exercise | 19,923 | $1.75M | Form 4 |
| Feb 19, 2026 | KIIL HARRY SKIPEVP & President Cardiovascular | Option exercise | 30,568 | $2.85M | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4